BETH WIMER: Open Payments
NPI 1932189941 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,423 in 183 payments from 17 companies in 2025. Trend: 2023 $1,718 · 2024 $2,321 · 2025 $3,423
Food & beverage: $3,339Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 55 | $1,040 |
| Janssen Biotech, Inc. | 32 | $908 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 34 | $430 |
| Phathom Pharmaceuticals, Inc. | 15 | $194 |
| PFIZER INC. | 15 | $162 |
| Madrigal Pharmaceuticals | 4 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $94 |
| Ipsen Biopharmaceuticals, Inc | 3 | $85 |
| Ardelyx, Inc. | 5 | $85 |
| Regeneron Healthcare Solutions, Inc. | 4 | $83 |
Products named: TREMFYA, XIFAXAN, RINVOQ, CREON, VOQUEZNA, SKYRIZI, LINZESS, DUPIXENT.
Industry payments across PA — which companies pay providers there.
